Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Discloses 10 Percent Stake Held by Mazama

NEW YORK (GenomeWeb News) – Mazama Capital Management owns a 10 percent stake in Affymetrix’s Class A common stock, according to a filing with the US Securities and Exchange Commission today.
 
The Portland, Oregon-based investment advisory firm owned 6,783,041 shares of Affy’s common stock as of April 15.
 
As reported yesterday by GenomeWeb Daily News, Affy said in an SEC filing that Fidelity Management & Research now owns 5,050,490 shares of the firm’s common stock, which represents a nearly 7.3 percent stake in Affy. Of that total amount, the Fidelity Growth Company Fund owns 4,403,190 shares, representing a stake of 6.34 percent in Affy as of April 30.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.